Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHMT2 | P34897 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8008689 | 0.89 | THRB (0.40) | SHMT2ALDH1A1MAPTNPC1HPGD | |
| SCHEMBL8009344 | 0.85 | MAPT (0.43) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8008606 | 0.85 | KDM4E (0.35) | ALDH1A1MAPTHPGDHTTKMT2A | |
| SCHEMBL6952092 | 0.84 | MAPT (0.39) | SHMT2ALDH1A1TP53MAPTNPC1 | |
| SCHEMBL6952098 | 0.84 | MAPT (0.39) | SHMT2ALDH1A1TP53MAPTNPC1 | |
| SCHEMBL8011512 | 0.84 | MEN1 (0.39) | ALDH1A1MAPTNPC1HPGDRAB9A | |
| SCHEMBL6947265 | 0.83 | KAT8 (0.42) | ALDH1A1MAPTHPGDSMN1; SMN2HTT | |
| SCHEMBL6947262 | 0.83 | KAT8 (0.42) | ALDH1A1MAPTHPGDSMN1; SMN2HTT | |
| SCHEMBL8008615 | 0.82 | KMT2A (0.35) | ALDH1A1MAPTNPC1HPGDRAB9A | |
| SCHEMBL8009323 | 0.81 | MAPT (0.37) | SHMT2ALDH1A1TP53MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6034099-A | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones | CELL PATHWAYS, INC. (US) | 2000-03-07 | — | — | US | claimed |
| US-6034099-A | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones | CELL PATHWAYS, INC. (US) | 2000-03-07 | — | — | US | disclosed |